{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:18:22Z","timestamp":1761895102995},"reference-count":22,"publisher":"The Journal of Rheumatology","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Observation of monosodium urate (MSU) crystal is the gold standard for diagnosis of gout, but is rarely performed in daily clinical practice, and diagnosis is based on clinical judgment. Our aim was to identify clinical and paraclinical data included in the European League Against Rheumatism recommendations (EULARr) and American College of Rheumatology proposed criteria (ACRp) for diagnosis of gout in patients with chronic gout according to their attending rheumatologists.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>This cross-sectional and multicenter study included consecutive patients from outpatient clinics with a diagnosis of gout by their attending rheumatologists according to their expertise. The frequency of each item from the ACRp and EULARr was determined. Possible combinations of the items that were frequent, clinically relevant, and simple to evaluate in daily practice were determined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>We studied 549 patients (96% men), mean age 50 \u00b1 14 years. Analysis of MSU crystals was performed in 15%. We selected 7 clinical criteria and 1 laboratory measure because of their frequency, importance, and simplicity to obtain: current or past history of: &gt; 1 attack of acute arthritis (93%); mono or oligoarthritis attacks (74%); rapid progression of pain and swelling (&lt; 24 hours; 74%); podagra (70%); erythema (56%); unilateral tarsitis (33%); tophi (52%); and hyperuricemia (93%). The chronic gout diagnosis (CGD) proposal comprised \u2265 4\/8 of these; 88% of patients had the criteria of the CGD proposal while 75% had 6\/11 ACRp criteria (p = 0.001). When analysis of MSU crystals was added, 90.1% (CGD) and 83.9% (ACRp) met the criteria (p = 0.004).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Current or past history of \u2265 4\/8 CGD parameters is highly suggestive of chronic gout.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.091385","type":"journal-article","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T20:55:52Z","timestamp":1276635352000},"page":"1743-1748","source":"Crossref","is-referenced-by-count":49,"title":["Diagnosis of Chronic Gout: Evaluating the American College of Rheumatology Proposal, European League Against Rheumatism Recommendations, and Clinical Judgment"],"prefix":"10.3899","volume":"37","author":[{"given":"INGRIS","family":"PEL\u00c1EZ-BALLESTAS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CLAUDIA","family":"HERN\u00c1NDEZ CUEVAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RUB\u00c9N","family":"BURGOS-VARGAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LIZANDRA","family":"HERN\u00c1NDEZ ROQUE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LEOBARDO","family":"TER\u00c1N","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JES\u00daS","family":"ESPINOZA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JORGE A.","family":"ESQUIVEL-VALERIO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAR\u00cdA VICTORIA","family":"GOYCOCHEA-ROBLES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FRANCISCO J.","family":"ACEVES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANA GUILAISNE","family":"BERNARD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LUCIO","family":"VENTURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CLARA","family":"SHUMSKY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ADOLFO","family":"HERN\u00c1NDEZ GARDU\u00d1O","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JANITZIA","family":"V\u00c1ZQUEZ-MELLADO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2010,6,15]]},"reference":[{"key":"2018112909233994000_37.8.1743.1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-54-3-452"},{"key":"2018112909233994000_37.8.1743.2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.7326\/0003-4819-131-10-199911160-00007","article-title":"Synovial fluid analysis for diagnosis of intercritical gout","volume":"131","author":"Pascual","year":"1999","journal-title":"Ann Intern Med"},{"key":"2018112909233994000_37.8.1743.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16000-5"},{"key":"2018112909233994000_37.8.1743.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7553.1315"},{"key":"2018112909233994000_37.8.1743.5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/art.1780220521","article-title":"Definitive diagnosis of gout by identification for urate crystals in asymptomatic metatarsophalangeal joints","volume":"22","author":"Agudelo","year":"1979","journal-title":"Arthritis Rheum"},{"key":"2018112909233994000_37.8.1743.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780200320"},{"key":"2018112909233994000_37.8.1743.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.055251"},{"key":"2018112909233994000_37.8.1743.8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.079970"},{"key":"2018112909233994000_37.8.1743.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.24166"},{"key":"2018112909233994000_37.8.1743.10","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181945b79"},{"key":"2018112909233994000_37.8.1743.11","doi-asserted-by":"crossref","unstructured":"Janssens HJ Janssen M van de Lisdonk EH Fransen J van Riel PLCM van Weel C . Limited validity of the American College of Rheumatology criteria for classifying patients with gout in primary care. Ann Rheum Dis 2010 Mar 16. E-pub ahead of print.","DOI":"10.1136\/ard.2009.123687"},{"key":"2018112909233994000_37.8.1743.12","first-page":"225","article-title":"El costo de las principales enfermedades reum\u00e1ticas inflamatorias desde la perspectiva del paciente en M\u00e9xico","volume":"144","author":"Mould-Quevedo","year":"2008","journal-title":"Gac M\u00e9d M\u00e9x"},{"key":"2018112909233994000_37.8.1743.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"2018112909233994000_37.8.1743.14","first-page":"S443","article-title":"Diagnosis of gout: Clinical, laboratory and radiologic findings","volume":"11","author":"Schlesinger","year":"2005","journal-title":"Am Care Manag Care"},{"key":"2018112909233994000_37.8.1743.15","doi-asserted-by":"crossref","unstructured":"Dore RK . The gout diagnosis. Cleve Clin J Med 2008;Suppl 5:S17\u201321.","DOI":"10.3949\/ccjm.75.Suppl_5.S17"},{"key":"2018112909233994000_37.8.1743.16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1699-258X(08)76168-0","article-title":"Diagn\u00f3stico de la artropat\u00eda microcristalina","volume":"4","author":"Pascual","year":"2008","journal-title":"Reumatol Clin"},{"key":"2018112909233994000_37.8.1743.17","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081195"},{"key":"2018112909233994000_37.8.1743.18","first-page":"498","article-title":"Gout in ambulatory care settings in the United States","volume":"35","author":"Krishnan","year":"2008","journal-title":"J Rheumatol"},{"key":"2018112909233994000_37.8.1743.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2008.12.013"},{"key":"2018112909233994000_37.8.1743.20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/35.4.306"},{"key":"2018112909233994000_37.8.1743.21","doi-asserted-by":"crossref","unstructured":"Saag K Choi H . Epidemiology, risk factors and lifestyle modifications for gout. Arthritis Res Ther 2006;Suppl 1:S2.","DOI":"10.1186\/ar1907"},{"key":"2018112909233994000_37.8.1743.22","first-page":"233","article-title":"Severe tophaceous gout. Characterization of low socioeconomic level patients from M\u00e9xico","volume":"24","author":"V\u00e1zquez-Mellado","year":"2006","journal-title":"Clin Exp Rheumatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.091385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T23:54:32Z","timestamp":1559174072000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.091385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,15]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,8,1]]},"published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.3899\/jrheum.091385"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.091385","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,15]]}}}